BMS drug Opdivo lands FDA approval for gastro cancers June 2, 2021 Auto Bot Markets & Regulations 0 The therapeutic has been approved as an adjuvant treatment for varieties of esophageal cancers in patients who have received neoadjuvant chemoradiotherapy.